Document ID: chunk:federal_register_of_legislation:F2025L00295:schedule:1:p1
Version: federal_register_of_legislation:F2025L00295
Segment Type: schedule
Provision Reference: sch 1 (pt 1/2)
Character Range: 2304–6121

Schedule 1—Reportable Medicines
Note: See section 5.

Reportable Medicines
Column 1              Column 2
Item                  Medicine
  1                   medicines that contain one of the following:
                          (a) cyproheptadine;
                          (b) levonorgestrel;
                          (c) pancreatic extract;
                          (d) theophylline;
                          (e) ulipristal
  2                   medicines that:
                          (a) contain barium sulfate as an active ingredient; or
                          (b) contain calcium gluconate, and are in the dosage form of an injection or a preparation for topical use; or
                          (c) contain folinic acid (as calcium folinate) when included in Schedule 2 to the current Poisons Standard; or
                          (d) contain glucagon, and are in the dosage form of an injection; or
                          (e) contain glyceryl trinitrate, and are for sublingual use; or
                          (f) contain hydroxocobalamin, and are in the dosage form of an injection; or
                          (g) contain isosorbide dinitrate when included in Schedule 3 to the current Poisons Standard; or
                          (h) contain magnesium sulfate as the only active ingredient, and are in the dosage form of an injection or an intravenous infusion; or
                          (i) contain mannitol as an active ingredient, and are in the dosage form of a powder for inhalation; or
                          (j) contain monobasic sodium phosphate as the only active ingredient; or
                          (k) contain naloxone, and are in the dosage form of an injection or a nasal spray; or
                          (l) contain salbutamol, and are in the dosage form of a preparation for inhalation; or
                          (m) contain terbutaline, and are in the dosage form of a preparation for inhalation
  3                   medicines for the treatment of anaphylaxis or management of cardiac arrest, that contain adrenaline (epinephrine) as the only active ingredient
  4                   medicines that are in the dosage form of an injection and that contain one of the following as the only active ingredient:
                      (a) phytomenadione;
                      (b) sodium bicarbonate;
                      (c) thiamine
  5                   medicines for intravenous phosphate supplementation, that are in the dosage form of an injection or an infusion and that contain one of the following as an active ingredient:
                          (a) dibasic potassium phosphate;
                          (b) dibasic sodium phosphate;
                          (c) monobasic potassium phosphate;
                          (d) monobasic sodium phosphate
  6                   medicines that contain 0.9% sodium chloride as the only active ingredient, and are in the dosage form of an injection or an intravenous infusion
  7                   medicines for the treatment of poisonings, that are in the dosage form of an injection and that contain one of the following as an active ingredient:
                      (a) ethanol;
                      (b) sodium calcium edetate;
                      (c) sodium nitrite;
                      (d) sodium thiosulfate
  8                   medicines for the treatment of poisonings or drug overdosage by oral ingestion, that contain activated charcoal as an active ingredient
  9                   medicines for the treatment of scabies, that contain one of the following as an active ingredient:
                          (a) benzyl benzoate;
                          (b) permethrin
  10                  medicines for oral bicarbonate supplementation, that contain sodium bicarbonate as an active